THE ALLIANCE | How pharma companies & physicians joined forces

Overview | Urology | Dermatology | Hair transplant surgery | Endocrinology | Merck & GSK | Study groups | References | People index

Dermatology

• Elise Olsen, MD
• Vera Price, MD
• Janet Roberts, MD
• Jerry Shapiro, MD
• Antonella Tosti, MD
• David Whiting, MD

Elise Olsen, MD
Professor of Dermatology and of Medicine, Duke University School of Medicine (profile)

• Merck: Finasteride Male Pattern Hair Loss Study Group
  • Investigator, Studies 047, 081, 087
• GSK: Dutasteride Alopecia Research Team
  • Received study grant
  • Consultant
• Co-authors: Gormley, Kaufman, Round, Waldstreicher, Rittmaster (GSK), Imperato-McGinley, Price, Roberts, Shapiro, Stough, Washenik, Whiting
• Papers
  • Kaufman 1998
  • Olsen 1999
  • Price 2000
  • Olsen 2002
  • Whiting 2003
  • Olsen 2005
  • Olsen 2006, sponsored by GSK
  • Olsen 2012

Vera Price, MD
Department of Dermatology, University of California, San Francisco

• Finasteride Male Pattern Hair Loss Study Group
  • Investigator, Studies 081, 087
• Co-authors: Gormley, Kaufman, Waldstreicher, Imperato-McGinley, Olsen, Roberts, Shapiro, Stough, Whiting
• Papers
  • Kaufman 1998
  • Shapiro 1998
  • Price 1999a. Treatment of hair loss. NEJM
  • Price 1999b. COI letter, NEJM
  • Roberts 1999a
  • Price 2000
  • Price 2002
  • Price 2006

Janet Roberts, MD
Northwest Cutaneous Research Specialists, Portland, OR; Oregon Health and Science University

• Finasteride Male Pattern Hair Loss Study Group
  • Investigator, Studies 081, 087
• Dutasteride Alopecia Research Team (GSK)
• Co-authors: Gormley, Kaufman, Waldstreicher, Imperato-McGinley, Olsen, Price, Shapiro, Stough, Tosti, Washenik, Whiting
• Papers
  • Kaufman 1998
  • Roberts 1999a
  • Roberts 1999b
  • Price 2000
  • Olsen 2002
  • Olsen 2005

Jerry Shapiro, MD
Department of Dermatology, University of British Columbia & Vancouver General Hospital; later moved to NYU Langone Medical Center

• Finasteride Male Pattern Hair Loss Study Group
  • Investigator, Study 089
• Consultant and speaker for Merck (disclosed in Fertig et al, 2017)
• Co-authors: Gormley, Kaufman, Round, Stoner, Olsen, Price, Roberts, Stough, Tosti, Washenik, Whiting
• Papers
  • Kaufman 1998
  • Shapiro 1998
  • Shapiro 2003
  • Olsen 2005
  • Fertig 2017 – Investigation of the plausibility of 5-alpha-reductase inhibitor syndrome
  • Young 2023
• Engagements with industry*
  • Highlighted: Advisor to Thirty Madison, owner of telehealth company Keeps (along with Dr. Antontella Tosti). Former investigator, consultant and speaker for Merck’s launch of Propecia.
  • Other engagements with: Aclaris Therapeutics (c), Applied Biology, Bayer (c), DS Laboratories, Eirion, Incyte (c), Johnson & Johnson (c), Kythera (c), L’Oreal Paris (c), Eli Lilly, Pfizer, RegenLab (pi), RepliCel Life Sciences (c,cf,st), Samumed (c).
• Publishing: Up to Date (author)
• Editorial roles: Regional Editor, International Journal of Trichology. Member, Editorial Board of Skin Appendage Disorders.
• Board positions: National Alopecia Areata Foundation (Scientific Board Member), Cicatricial Alopecia Research Foundation (Board of Directors)

* Key: a, author; b, Board of Directors; c, consultant; cf, cofounder; sp, speaker; st, stockholder. Sources: Fertig et al, 2017; Ho & Shapiro 2019; Young et al, 2023.

Antonella Tosti, MD
As of 2004: Department of Dermatology, University of Bologna; later moved to University of Miami

• Consultant and speaker for Merck (disclosed as ‘over 3 years ago’ in Fertig 2017; dates unknown)
• Co-authors: Kaufman, Roberts, Shapiro, Whiting
• Papers
  • Tosti 1999a
  • Tosti 1999b
  • Tosti 2000
  • Van Neste 2000
  • Tosti 2001
  • Tosti 2004
  • Tosti 2009
  • Fertig 2017 – Investigation of the plausibility of 5-alpha-reductase inhibitor syndrome
  • Young 2023 – Focused on telehealth company Keeps where Dr. Tosti is an Advisor. Co-authored with: J. Shapiro, also an Advisor; executive of parent company Thirty Madison; and medical officer at Keeps.
  • Dr. Tosti was an author or co-author of 30 papers in which finasteride is mentioned (per PubMed search)
• Engagements with industry*
  • Highlighted: Advisor to Thirty Madison, owner of telehealth company Keeps (along with Dr. Jerry Shapiro). Co-author of finasteride trial report with Merck researchers; former consultant and speaker for Merck.
  • Other engagements with: Aclaris, Almirall, Bristol Myers Squibb, DS Laboratories, Eli Lilly, Incyte (c,pi), Kythera, Monat Global, Myovant, Nutrafol, Pfizer, Procter & Gamble.
• Editorial roles: co-Editor-in-Chief of Skin Appendage Disorders.
• Board position: National Alopecia Areata Foundation (Scientific Board Member)

* Key: a, author; c, consultant; cf, cofounder; sp, speaker; st, stockholder. Sources: Fertig et al, 2017; Gupta et al, 2019; Young et al, 2023.

David Whiting, MD (d. 2018)
Departments of Dermatology and Pediatrics, University of Texas, Southwestern Medical Center at Dallas, and the Baylor Hair Research and Treatment Center, Dallas (1999)
Dallas Associated Dermatologists (2003)

• Merck relationships
  • Member, Finasteride Male Pattern Hair Loss Study Group
    • Investigator, Studies 081, 087
• GSK relationships
  • Dutasteride Alopecia Research Team
• Co-authors: Gormley, Kaufman, Round, Waldstreicher, Rittmaster (GSK), Imperato-McGinley, Olsen, Price, Roberts, Shapiro, Stough, Tosti, Washenik
• Papers
  • Whiting 1998
  • Drake 1999
  • Whiting 1999
  • Price 2000
  • Whiting 2001a
  • Whiting 2001b
  • Olsen 2002
  • Whiting 2003
  • Olsen 2005
  • Stough 2005
  • Olsen 2006 (GSK-sponsored)
  • Olsen 2012

Sources of disclosures for Dr. Jerry Shapiro & Dr. Antonella Tosti: Fertig et al, 2017; Gupta et al, 2019; Ho & Shapiro 2019; Young et al, 2023.